Covid-19 vaccine trial from AstraZeneca and the University of Oxford can resume in U.S., according to a person familiar with the matter
Federal health regulators have decided to allow the resumption of U.S. studies of a leading Covid-19 vaccine candidate from AstraZeneca PLC and the University of Oxford, according to a person familiar with the matter and materials reviewed by The Wall Street Journal.examination of two cases of a possible neurological side effect
that emerged in two people testing the shot. The agency told AstraZeneca on Friday that the late-stage trial in the U.S. can resume, according to the person and materials. The FDA didn’t find the vaccine was responsible for the two cases, though it couldn’t rule out a link either, the person said. The agency plans to require researchers to inform study subjects of the cases and monitor them for any related neurological events, such as numbness, the person said.
AstraZeneca declined to comment. An FDA spokeswoman didn’t immediately respond to a request for comment.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
AstraZeneca COVID-19 vaccine trial Brazil volunteer dies, trial to continueBrazilian health authority Anvisa said on Wednesday that a volunteer in a clinical trial of the COVID-19 vaccine developed by AstraZeneca and Oxford University had died but added that the trial would continue.
Read more »
AstraZeneca COVID-19 vaccine trial volunteer has died, Brazil health authority saysBrazilian health authority Anvisa said on Wednesday that a volunteer in a clinical trial of the COVID-19 vaccine developed by AstraZeneca and Oxford University has died, stating it had received data from an investigation into the matter.
Read more »
AstraZeneca COVID-19 vaccine trial Brazil volunteer dies, trial to continueBrazilian health authority Anvisa said on Wednesday that a volunteer in a clinical trial of the COVID-19 vaccine developed by AstraZeneca and Oxford University had died but added that the trial would continue.
Read more »
AstraZeneca COVID-19 vaccine trial Brazil volunteer dies, trial to continueBrazilian health authority Anvisa said on Wednesday that a volunteer in a clinical trial of the COVID-19 vaccine developed by AstraZeneca and Oxford University had died but added that the trial would continue.
Read more »
Volunteer in AstraZeneca Covid-19 vaccine trial dies in BrazilClinical trials for the drugmaker's vaccine remain on hold in the United States.
Read more »
Covid-19 vaccine volunteer in Brazil's AstraZeneca trial diesA volunteer in Brazil's trial of AstraZeneca's experimental coronavirus vaccine has died, the Brazilian health agency Anvisa announced on Wednesday, but organizers said there was no reason to stop the trial -- an indication that the death is not linked to the vaccine.
Read more »